In the quest for a longer, healthier life, exercise advice can sometimes feel confusing. From High-Intensity Interval ...

An increasing number of people are dying of colorectal cancer at a young age, including those as young as 20. Actor James Van Der Beek, who was diagnosed with colorectal cancer in 2023, died at age 48 ...

Colon cancer symptoms can be subtle. While lifestyle changes can help reduce your risk, open communication with your family and doctor is essential.

The trial-to-trial variability of neuronal responses and the correlated response variability among neurons are modulated by visual stimulus size in a manner that depends on cortical layer, suggesting ...

Featuring a new blade-style design, these premium headphones can customize noise cancellation to suit different environments ...

Streaming companies experience fast business expansion, but their stock values display extreme volatility. The combination of advertising cycles, increasing spo ...

A new study reveals that the next generation of blockchain defenses will not rely on fixed rules alone but on adaptive, learning-based systems capable of evolving alongside intelligent adversaries.

Training large models requires building or upgrading data centers. But centralized infrastructure is now running into hard physical limits. To improve this infr ...

The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2025 Earnings Call Transcript February 11, 2026 Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-0.

BREAKWATER trial Cohort 3 analysis demonstrated statistically significant and clinically meaningful improvement in ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...